Arbutus Biopharma (ABUS) FCF Margin Growth (3y) (2016 - 2026)
Arbutus Biopharma (ABUS) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arbutus Biopharma |
882.62 Mn |
882.62 Mn |
- |
40,549.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
40,549.00 |
| Dec 31, 2025 |
-17,109.00 |
| Sep 30, 2025 |
-78,405.00 |
| Jun 30, 2025 |
-267.00 |
| Mar 31, 2025 |
-92,242.00 |
| Dec 31, 2024 |
-4,745.00 |
| Sep 30, 2024 |
-106,790.00 |
| Jun 30, 2024 |
-21,174.00 |
| Mar 31, 2024 |
-41,474.00 |
| Dec 31, 2023 |
-17,057.00 |
| Sep 30, 2023 |
33,171.00 |
| Jun 30, 2023 |
14,666.00 |
| Mar 31, 2023 |
62,640.00 |
| Dec 31, 2022 |
55,484.00 |
| Sep 30, 2022 |
45,950.00 |
| Jun 30, 2022 |
258,879.00 |
| Mar 31, 2022 |
260,969.00 |
| Dec 31, 2021 |
41,776.00 |
| Sep 30, 2021 |
36,623.00 |
| Jun 30, 2021 |
82,208.00 |
